Target intelligence / Profile preview

Capillary permeability regulators

Molecular classification
Other
01

Overview

Capillary permeability regulators are a heterogeneous group of molecular factors and receptors that govern the movement of fluids, ions, and macromolecules across the vascular endothelium. These regulators include pro-permeability factors such as vascular endothelial growth factor (VEGF), histamine, and bradykinin, as well as stabilizing factors like angiopoietin-1 and sphingosine-1-phosphate (S1P). They function by modulating the assembly and disassembly of endothelial cell-cell junctions, specifically tight junctions and adherens junctions, and by regulating transcellular transport mechanisms. In pathological states such as inflammation, cancer, and diabetes, an imbalance in these regulators leads to excessive vascular leakage, resulting in tissue edema, impaired organ function, and disease progression. Therapeutic interventions often target these pathways to restore barrier function; for example, anti-VEGF therapies are widely used in treating wet age-related macular degeneration and diabetic retinopathy. Additionally, drugs like icatibant target bradykinin receptors to treat hereditary angioedema, while S1P modulators are explored for their ability to stabilize the endothelial barrier in various inflammatory conditions.

Other names
Vascular permeability factorsCapillary stabilizing agentsEndothelial barrier regulatorsVasoprotectivesVascular permeability regulators
02

Mechanism of action

Drugs targeting capillary permeability regulators typically act by either antagonizing pro-permeability factors (such as VEGF, histamine, or bradykinin) or by enhancing the stability of endothelial cell-cell junctions (e.g., through S1P receptor modulation or Tie2 activation).

03

Biological functions

Signal transductionImmune responseFluid homeostasisAngiogenesisCell-cell adhesion
04

Disease associations

InflammationCancerCardiovascular diseaseEdemaDiabetic retinopathySepsisSystemic capillary leak syndrome
05

Safety considerations

Risk of thrombosisImpaired wound healingHypertensionHypotensionFluid overload
06

Interacting drugs

Bevacizumab

7 more in the full profile.

07

Biomarkers

Vascular endothelial growth factor (VEGF) levelsSoluble fms-like tyrosine kinase-1 (sFlt-1)Angiopoietin-2 levelsAlbumin-to-creatinine ratioHematocrit

Beyond the preview

Go deeper on Capillary permeability regulators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capillary permeability regulators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call